Main Content start here
Main Layout
Report Description

Report Description

Forecast Period

2027-2031

Market Size (2025)

USD 1.86 Billion

CAGR (2026-2031)

5.67%

Fastest Growing Segment

Above 500 m3/d

Largest Market

North America

Market Size (2031)

USD 2.59 Billion

Market Overview

The Global Membrane Aerated Biofilm Reactor Market will grow from USD 1.86 Billion in 2025 to USD 2.59 Billion by 2031 at a 5.67% CAGR. The Membrane Aerated Biofilm Reactor is a biological wastewater treatment technology that utilizes gas-permeable membranes to deliver oxygen directly to a biofilm, enabling simultaneous nitrification and denitrification within a single vessel. This process employs bubble-free aeration, which significantly enhances oxygen transfer efficiency compared to conventional diffusion methods. The primary drivers supporting market growth include the increasing enforcement of stringent nutrient removal regulations and the necessity to retrofitting existing infrastructure to increase capacity without expanding physical footprints. Furthermore, the global water sector's shift toward energy neutrality accelerates adoption, as these systems offer substantial operational cost reductions through optimized aeration mechanics.

However, widespread expansion faces a significant challenge regarding the high initial capital expenditure required for specialized membrane modules and the technical complexities associated with long-term biofilm control and fouling management. These maintenance demands can sometimes deter adoption in smaller municipalities with limited technical resources. Despite these hurdles, the operational efficiency remains a strong selling point for utility operators. According to the International Water Association, in 2024, MABR technology was reported to reduce aeration energy consumption by up to 50% compared to traditional activated sludge processes, positioning it as a critical component for sustainable urban water management.

Key Market Drivers

The demand for retrofitting and upgrading aging infrastructure serves as a critical growth engine, primarily because MABR technology allows utilities to intensify treatment capacity within existing basin footprints. This "drop-in" capability is essential for municipalities facing strict nutrient discharge limits but lacking the land or capital for new civil construction. By suspending membrane modules directly into established anoxic zones, operators can simultaneously support nitrifying biofilms and suspended sludge, significantly boosting performance. For instance, according to WaterProjectsOnline, December 2024, the retrofit of Severn Trent Water’s Monkmoor Sewage Treatment Works utilizing 48 OxyMem MABR modules achieved an ammonia removal rate of 243 kilograms of nitrogen per day, surpassing the design target of 162 kilograms.

Concurrently, rapid urbanization and the expansion of industrial activities are accelerating adoption, as high-load manufacturing facilities require robust solutions to manage complex effluents. Industrial sectors, particularly paper and food processing, are increasingly leveraging these reactors to handle high-strength wastewater while adhering to environmental compliance. According to Fluence Corporation, March 2024, this industrial demand was highlighted when the company secured a $2.3 million contract to provide a 7,500 cubic meter per day MABR plant for a recycled paper mill in Italy. The broader market momentum resulting from these drivers is evident in regional procurement data; according to Fluence Corporation, in March 2024, the company reported $3.3 million in municipal bookings in North America for the first two months of the year alone, eclipsing the region's total sales for the entire previous year.

Download Free Sample Report

Key Market Challenges

The high initial capital expenditure required for specialized membrane modules presents a formidable barrier to the widespread adoption of Membrane Aerated Biofilm Reactor technology. While the system promises long-term operational savings, the upfront investment for these advanced aeration units is significantly higher than that of conventional diffusers. This financial hurdle is compounded by the technical intricacies of managing biofilm thickness and preventing fouling, which necessitate skilled personnel and rigorous maintenance protocols that are often unavailable in smaller utility operations. Consequently, risk-averse municipal decision-makers frequently defer upgrading to this efficient architecture, viewing the immediate procurement and training costs as prohibitive despite the potential for future efficiency gains.

This hesitation is reinforced by the broader financial strain currently affecting the global water sector, where limited budgets cannot easily accommodate premium infrastructure investments. According to the International Water Association, in 2024, environmental charges regarding wastewater treatment exceeded 50% of the total water bill in one-third of surveyed cities worldwide. This statistic underscores the intense pressure on utility budgets, directly limiting the fiscal capacity of operators to absorb the elevated costs associated with deploying advanced MABR infrastructure. Such financial constraints effectively hamper the market's growth trajectory by restricting entry to only the most capital-rich utility providers.

Key Market Trends

The proliferation of modular and containerized MABR units is reshaping the market by providing flexible, plug-and-play treatment solutions for decentralized applications. Unlike centralized infrastructure which requires extensive civil works, these pre-packaged systems allow municipalities and private developers to rapidly deploy biological treatment capacity in remote or space-constrained locations. This delivery model significantly reduces installation timelines and upfront construction costs, making high-performance nutrient removal accessible to smaller communities and commercial developments that lack the resources for custom-built plants. The commercial viability of this segment is accelerating; according to Fluence Corporation, April 2024, in its 'Quarterly Activities Report', the company’s Smart Product Solutions division, which anchors its modular MABR portfolio, achieved a 50% increase in revenue during the first quarter compared to the same period in the previous year.

Simultaneously, the market is experiencing a decisive shift toward energy-neutral and low-carbon operations, driven by the global water sector's commitment to net-zero emission targets. Utilities are increasingly prioritizing MABR technology not just for compliance, but as a strategic tool to decouple wastewater treatment from high electricity consumption and associated carbon footprints. By utilizing passive aeration membranes that eliminate the need for energy-intensive blowers, these systems significantly lower Scope 2 emissions, justifying premium investments through long-term sustainability gains. This strategic focus is evident in major utility capital allocations; according to Water Industry Journal, March 2024, Severn Trent Water invested £6.2 million in the Monkmoor MABR upgrade project specifically to align the facility's expanded treatment capabilities with the company's broader carbon reduction ambitions.

Segmental Insights

The Above 500 m3/d segment is currently the fastest-growing category within the Global Membrane Aerated Biofilm Reactor Market, primarily driven by the increasing demand for municipal wastewater treatment intensification. Utility operators are prioritizing this capacity range to retrofit existing infrastructure, which allows them to expand treatment capabilities without requiring additional land. As regulatory bodies like the U.S. Environmental Protection Agency enforce stricter nitrogen and phosphorus discharge limits, these larger-scale systems provide a compliant, energy-efficient solution. Consequently, municipalities are rapidly adopting this technology to modernize aging facilities while optimizing operational expenditures.

Regional Insights

North America maintains a dominant position in the Global Membrane Aerated Biofilm Reactor market, primarily driven by stringent wastewater discharge standards established by the United States Environmental Protection Agency. These rigorous regulatory frameworks require municipalities to modernize aging water infrastructure to enhance nutrient removal processes. The region favors this technology because it allows facilities to expand treatment capacity within existing tanks, offering a cost-effective solution for retrofitting projects. Furthermore, the growing emphasis on energy efficiency in industrial applications supports the widespread adoption of these systems across the United States and Canada, ensuring sustained market leadership.

Recent Developments

  • In August 2025, DuPont announced that its OxyMem Membrane Aerated Biofilm Reactor modules were deployed for the first time in New Zealand at a wastewater treatment plant in Raglan. The project, commissioned by Apex Water, combined the company's MABR technology with its MemPulse Membrane Bioreactor system to create a robust multi-technology solution. This combination was selected to help the local water utility, Watercare, achieve lower total nitrogen concentrations and comply with strict land discharge regulations. The facility was scheduled to commence treatment operations during this month, aiming to provide consistent long-term performance and additional capacity for future demand.
  • In March 2025, Fluence Corporation Limited reported a strong start to the first quarter by securing multiple contracts with municipal and industrial customers in North America, with sales exceeding $6 million year-to-date. The company’s Municipal Water and Wastewater Group was awarded a contract to provide a containerized wastewater treatment plant for the Westcott housing development in Rancho Lucerne, California. This project will utilize the company's Aspiral Flex Membrane Aerated Biofilm Reactor technology to treat 150,000 gallons per day, meeting stringent recycled water regulations. Additionally, the company secured a contract for a similar plant at Kualoa Ranch in Hawaii to treat 35,000 gallons per day.
  • In July 2024, it was reported that the Central Contra Costa Sanitary District in California was actively conducting a pilot test of a Membrane Aerated Biofilm Reactor system supplied by Veolia. This initiative was highlighted following the approval of a new nutrient watershed permit by the San Francisco Bay Regional Water Quality Control Board, which mandates significant reductions in inorganic nitrogen. The pilot project, which commenced in April and was scheduled to run through November, aimed to evaluate the efficacy of the technology in maximizing the value of existing infrastructure while meeting stricter environmental regulations without the need for constructing expensive new aeration basins.
  • In March 2024, Fluence Corporation Limited announced that it had secured several new contracts for its water and wastewater treatment solutions, marking the entry of its Membrane Aerated Biofilm Reactor technology into Colorado and Indiana for the first time. The company was awarded two industrial wastewater and biogas contracts valued at $3.7 million, alongside significant municipal bookings in North America. Specifically, the company secured a project to supply a wastewater treatment plant to the Sagewood Pointe Homeowners Association in Colorado, which included its Aspiral system. Additionally, an order was received for an Aspiral unit and an equalization tank for Needmore Elementary School in Indiana.

Key Market Players

  • Xylem Inc.
  • Pentair plc
  • Aqua-Aerobic Systems, Inc.
  • EnviroChemie GmbH
  • BASF SE
  • Emerson Electric Co.
  • ITT Inc.
  • Tetra Tech, Inc.

By Type

By Application

By Treatment Capacity

By Region

  • Modules
  • Containerized
  • Concrete Plants
  • Municipal
  • Industrial
  • 1 m3/d - 50 m3/d
  • 50 m3/d - 150 m3/d
  • 150 m3/d - 500 m3/d
  • Above 500 m3/d
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Report Scope:

In this report, the Global Membrane Aerated Biofilm Reactor Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Membrane Aerated Biofilm Reactor Market, By Type:
  • Modules
  • Containerized
  • Concrete Plants
  • Membrane Aerated Biofilm Reactor Market, By Application:
  • Municipal
  • Industrial
  • Membrane Aerated Biofilm Reactor Market, By Treatment Capacity:
  • 1 m3/d - 50 m3/d
  • 50 m3/d - 150 m3/d
  • 150 m3/d - 500 m3/d
  • Above 500 m3/d
  • Membrane Aerated Biofilm Reactor Market, By Region:
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Membrane Aerated Biofilm Reactor Market.

Available Customizations:

Global Membrane Aerated Biofilm Reactor Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Membrane Aerated Biofilm Reactor Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.  Markets Covered

1.2.2.  Years Considered for Study

1.2.3.  Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Membrane Aerated Biofilm Reactor Market Outlook

5.1.  Market Size & Forecast

5.1.1.  By Value

5.2.  Market Share & Forecast

5.2.1.  By Type (Modules, Containerized, Concrete Plants)

5.2.2.  By Application (Municipal, Industrial)

5.2.3.  By Treatment Capacity (1 m3/d - 50 m3/d, 50 m3/d - 150 m3/d, 150 m3/d - 500 m3/d, Above 500 m3/d)

5.2.4.  By Region

5.2.5.  By Company (2025)

5.3.  Market Map

6.    North America Membrane Aerated Biofilm Reactor Market Outlook

6.1.  Market Size & Forecast

6.1.1.  By Value

6.2.  Market Share & Forecast

6.2.1.  By Type

6.2.2.  By Application

6.2.3.  By Treatment Capacity

6.2.4.  By Country

6.3.    North America: Country Analysis

6.3.1.    United States Membrane Aerated Biofilm Reactor Market Outlook

6.3.1.1.  Market Size & Forecast

6.3.1.1.1.  By Value

6.3.1.2.  Market Share & Forecast

6.3.1.2.1.  By Type

6.3.1.2.2.  By Application

6.3.1.2.3.  By Treatment Capacity

6.3.2.    Canada Membrane Aerated Biofilm Reactor Market Outlook

6.3.2.1.  Market Size & Forecast

6.3.2.1.1.  By Value

6.3.2.2.  Market Share & Forecast

6.3.2.2.1.  By Type

6.3.2.2.2.  By Application

6.3.2.2.3.  By Treatment Capacity

6.3.3.    Mexico Membrane Aerated Biofilm Reactor Market Outlook

6.3.3.1.  Market Size & Forecast

6.3.3.1.1.  By Value

6.3.3.2.  Market Share & Forecast

6.3.3.2.1.  By Type

6.3.3.2.2.  By Application

6.3.3.2.3.  By Treatment Capacity

7.    Europe Membrane Aerated Biofilm Reactor Market Outlook

7.1.  Market Size & Forecast

7.1.1.  By Value

7.2.  Market Share & Forecast

7.2.1.  By Type

7.2.2.  By Application

7.2.3.  By Treatment Capacity

7.2.4.  By Country

7.3.    Europe: Country Analysis

7.3.1.    Germany Membrane Aerated Biofilm Reactor Market Outlook

7.3.1.1.  Market Size & Forecast

7.3.1.1.1.  By Value

7.3.1.2.  Market Share & Forecast

7.3.1.2.1.  By Type

7.3.1.2.2.  By Application

7.3.1.2.3.  By Treatment Capacity

7.3.2.    France Membrane Aerated Biofilm Reactor Market Outlook

7.3.2.1.  Market Size & Forecast

7.3.2.1.1.  By Value

7.3.2.2.  Market Share & Forecast

7.3.2.2.1.  By Type

7.3.2.2.2.  By Application

7.3.2.2.3.  By Treatment Capacity

7.3.3.    United Kingdom Membrane Aerated Biofilm Reactor Market Outlook

7.3.3.1.  Market Size & Forecast

7.3.3.1.1.  By Value

7.3.3.2.  Market Share & Forecast

7.3.3.2.1.  By Type

7.3.3.2.2.  By Application

7.3.3.2.3.  By Treatment Capacity

7.3.4.    Italy Membrane Aerated Biofilm Reactor Market Outlook

7.3.4.1.  Market Size & Forecast

7.3.4.1.1.  By Value

7.3.4.2.  Market Share & Forecast

7.3.4.2.1.  By Type

7.3.4.2.2.  By Application

7.3.4.2.3.  By Treatment Capacity

7.3.5.    Spain Membrane Aerated Biofilm Reactor Market Outlook

7.3.5.1.  Market Size & Forecast

7.3.5.1.1.  By Value

7.3.5.2.  Market Share & Forecast

7.3.5.2.1.  By Type

7.3.5.2.2.  By Application

7.3.5.2.3.  By Treatment Capacity

8.    Asia Pacific Membrane Aerated Biofilm Reactor Market Outlook

8.1.  Market Size & Forecast

8.1.1.  By Value

8.2.  Market Share & Forecast

8.2.1.  By Type

8.2.2.  By Application

8.2.3.  By Treatment Capacity

8.2.4.  By Country

8.3.    Asia Pacific: Country Analysis

8.3.1.    China Membrane Aerated Biofilm Reactor Market Outlook

8.3.1.1.  Market Size & Forecast

8.3.1.1.1.  By Value

8.3.1.2.  Market Share & Forecast

8.3.1.2.1.  By Type

8.3.1.2.2.  By Application

8.3.1.2.3.  By Treatment Capacity

8.3.2.    India Membrane Aerated Biofilm Reactor Market Outlook

8.3.2.1.  Market Size & Forecast

8.3.2.1.1.  By Value

8.3.2.2.  Market Share & Forecast

8.3.2.2.1.  By Type

8.3.2.2.2.  By Application

8.3.2.2.3.  By Treatment Capacity

8.3.3.    Japan Membrane Aerated Biofilm Reactor Market Outlook

8.3.3.1.  Market Size & Forecast

8.3.3.1.1.  By Value

8.3.3.2.  Market Share & Forecast

8.3.3.2.1.  By Type

8.3.3.2.2.  By Application

8.3.3.2.3.  By Treatment Capacity

8.3.4.    South Korea Membrane Aerated Biofilm Reactor Market Outlook

8.3.4.1.  Market Size & Forecast

8.3.4.1.1.  By Value

8.3.4.2.  Market Share & Forecast

8.3.4.2.1.  By Type

8.3.4.2.2.  By Application

8.3.4.2.3.  By Treatment Capacity

8.3.5.    Australia Membrane Aerated Biofilm Reactor Market Outlook

8.3.5.1.  Market Size & Forecast

8.3.5.1.1.  By Value

8.3.5.2.  Market Share & Forecast

8.3.5.2.1.  By Type

8.3.5.2.2.  By Application

8.3.5.2.3.  By Treatment Capacity

9.    Middle East & Africa Membrane Aerated Biofilm Reactor Market Outlook

9.1.  Market Size & Forecast

9.1.1.  By Value

9.2.  Market Share & Forecast

9.2.1.  By Type

9.2.2.  By Application

9.2.3.  By Treatment Capacity

9.2.4.  By Country

9.3.    Middle East & Africa: Country Analysis

9.3.1.    Saudi Arabia Membrane Aerated Biofilm Reactor Market Outlook

9.3.1.1.  Market Size & Forecast

9.3.1.1.1.  By Value

9.3.1.2.  Market Share & Forecast

9.3.1.2.1.  By Type

9.3.1.2.2.  By Application

9.3.1.2.3.  By Treatment Capacity

9.3.2.    UAE Membrane Aerated Biofilm Reactor Market Outlook

9.3.2.1.  Market Size & Forecast

9.3.2.1.1.  By Value

9.3.2.2.  Market Share & Forecast

9.3.2.2.1.  By Type

9.3.2.2.2.  By Application

9.3.2.2.3.  By Treatment Capacity

9.3.3.    South Africa Membrane Aerated Biofilm Reactor Market Outlook

9.3.3.1.  Market Size & Forecast

9.3.3.1.1.  By Value

9.3.3.2.  Market Share & Forecast

9.3.3.2.1.  By Type

9.3.3.2.2.  By Application

9.3.3.2.3.  By Treatment Capacity

10.    South America Membrane Aerated Biofilm Reactor Market Outlook

10.1.  Market Size & Forecast

10.1.1.  By Value

10.2.  Market Share & Forecast

10.2.1.  By Type

10.2.2.  By Application

10.2.3.  By Treatment Capacity

10.2.4.  By Country

10.3.    South America: Country Analysis

10.3.1.    Brazil Membrane Aerated Biofilm Reactor Market Outlook

10.3.1.1.  Market Size & Forecast

10.3.1.1.1.  By Value

10.3.1.2.  Market Share & Forecast

10.3.1.2.1.  By Type

10.3.1.2.2.  By Application

10.3.1.2.3.  By Treatment Capacity

10.3.2.    Colombia Membrane Aerated Biofilm Reactor Market Outlook

10.3.2.1.  Market Size & Forecast

10.3.2.1.1.  By Value

10.3.2.2.  Market Share & Forecast

10.3.2.2.1.  By Type

10.3.2.2.2.  By Application

10.3.2.2.3.  By Treatment Capacity

10.3.3.    Argentina Membrane Aerated Biofilm Reactor Market Outlook

10.3.3.1.  Market Size & Forecast

10.3.3.1.1.  By Value

10.3.3.2.  Market Share & Forecast

10.3.3.2.1.  By Type

10.3.3.2.2.  By Application

10.3.3.2.3.  By Treatment Capacity

11.    Market Dynamics

11.1.  Drivers

11.2.  Challenges

12.    Market Trends & Developments

12.1.  Merger & Acquisition (If Any)

12.2.  Product Launches (If Any)

12.3.  Recent Developments

13.    Global Membrane Aerated Biofilm Reactor Market: SWOT Analysis

14.    Porter's Five Forces Analysis

14.1.  Competition in the Industry

14.2.  Potential of New Entrants

14.3.  Power of Suppliers

14.4.  Power of Customers

14.5.  Threat of Substitute Products

15.    Competitive Landscape

15.1.  Xylem Inc.

15.1.1.  Business Overview

15.1.2.  Products & Services

15.1.3.  Recent Developments

15.1.4.  Key Personnel

15.1.5.  SWOT Analysis

15.2.  Pentair plc

15.3.  Aqua-Aerobic Systems, Inc.

15.4.  EnviroChemie GmbH

15.5.  BASF SE

15.6.  Emerson Electric Co.

15.7.  ITT Inc.

15.8.  Tetra Tech, Inc.

16.    Strategic Recommendations

17.    About Us & Disclaimer

Figures and Tables

Frequently asked questions

Frequently asked questions

The market size of the Global Membrane Aerated Biofilm Reactor Market was estimated to be USD 1.86 Billion in 2025.

North America is the dominating region in the Global Membrane Aerated Biofilm Reactor Market.

Above 500 m3/d segment is the fastest growing segment in the Global Membrane Aerated Biofilm Reactor Market.

The Global Membrane Aerated Biofilm Reactor Market is expected to grow at 5.67% between 2026 to 2031.

Related Reports

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.